These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1945452)

  • 1. [Physiology and pathophysiology of postnatal pulmonary adaptation. 2: Pathophysiology].
    Schwartze H
    Padiatr Grenzgeb; 1991; 30(5):355-68. PubMed ID: 1945452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal lung function in very immature infants with and without RDS.
    Kavvadia V; Greenough A; Itakura Y; Dimitriou G
    J Perinat Med; 1999; 27(5):382-7. PubMed ID: 10642959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited disorders of neonatal lung diseases.
    Yurdakök M
    Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome.
    Tsao PN; Wei SC; Chou HC; Su YN; Chen CY; Hsieh FJ; Hsieh WS
    Pediatr Pulmonol; 2005 May; 39(5):461-5. PubMed ID: 15786439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein leaks and surfactant dysfunction in the pathogenesis of respiratory distress syndrome.
    Jobe A
    Eur Respir J Suppl; 1989 Mar; 3():27s-32s. PubMed ID: 2742683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.
    Notter RH
    Semin Perinatol; 1988 Jul; 12(3):180-212. PubMed ID: 3041603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
    Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
    Wirbelauer J; Speer CP
    J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
    Jobe A
    Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late surfactant treatment in preterm triplets.
    Park YI; Delmore P; Bloom BT
    Kans Med; 1989 Dec; 90(12):335-6. PubMed ID: 2635234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O; Kale G
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.
    Notter RH; Shapiro DL
    Clin Perinatol; 1987 Sep; 14(3):433-79. PubMed ID: 3311535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The era of pulmonary surfactant from Laplace to nowadays.
    Parmigiani S; Solari E
    Acta Biomed; 2003 Aug; 74(2):69-75. PubMed ID: 14509914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obstructive apnea and periodic respiration in premature infants].
    Schlüter B; Buschatz D; Trowitzsch E; Andler W
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):805-12. PubMed ID: 8264684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep apnea in infants who succumb to the sudden infant death syndrome.
    Schechtman VL; Harper RM; Wilson AJ; Southall DP
    Pediatrics; 1991 Jun; 87(6):841-6. PubMed ID: 2034488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.